GRAIL (GRAL) Marketable Securities: $753.8 Mil (As of Mar. 2026)


GRAL GRAIL Inc GRAL
12 GF Score
Price $72.00
! 2 Warning Signs
View Full Analysis

What is GRAIL Marketable Securities?

GRAIL GRAL -5.00% 12 Marketable Securities is $753.8 Mil as of Mar. 2026. GuruFocus rates GRAL with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. GRAIL's Marketable Securities for the quarter that ended in Mar. 2026 was $753.8 Mil.

GRAIL's annual Marketable Securities increased from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($549.2 Mil) and increased from Dec. 2024 ($549.2 Mil) to Dec. 2025 ($654.7 Mil).

GRAIL  (NAS:GRAL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

GRAIL Marketable Securities Related Terms

GRAIL Marketable Securities Historical Data

* Premium members only.

The historical data trend for GRAIL's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GRAIL Marketable Securities Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 401.16 0.00 0.00 549.24 654.70

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 540.69 475.33 413.24 654.70 753.76
GRAL
12GF Score
GRAIL Inc GRAL
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GRAIL Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $753.8 Mil mean?
GRAIL (GRAL) has a Marketable Securities of $753.8 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on GRAIL and its competitors.
Is GRAIL's Marketable Securities too high?
GRAIL's current Marketable Securities is $753.8 Mil. Overall, GRAIL has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does GRAIL's Marketable Securities compare to ADPT and WGS?
GRAIL's Marketable Securities of $753.8 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on GRAIL and its competitors. GRAIL's current Marketable Securities is $753.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GRAIL stock overvalued right now?
GRAIL (GRAL) has a current Marketable Securities of $753.8 Mil. The current Marketable Securities is $753.8 Mil. GRAIL's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For GRAIL (GRAL), the current Marketable Securities is $753.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GRAIL Business Description

Other Exchanges NL0:Germany
Address 1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
12GF Score

Get the complete analysis for GRAL

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.00
Price